Association between sociodemographic variables, healthy habits and stress with diabesity [0.03%]
社会人口学特征、健康习惯和压力与糖尿病肥胖症的相关性分析
Ángel Arturo López-González,Emilio Martínez-Almoyna Rifá,Hernán Paublini Oliveira et al.
Ángel Arturo López-González et al.
Introduction: Diabesity is a pathological condition that combines obesity and type 2 diabetes in the same individual. Due to the current rise in both conditions, the prevalence of diabesity is increasing worldwide. Its et...
Efficiency of fixed-dose combinations of statin and ezetimibe in the treatment of hypercholesterolemia [0.03%]
他汀和依折麦布定比值复合制剂治疗高胆固醇血症的疗效分析
Carlos Guijarro,Angel Diaz,Eva Moreno et al.
Carlos Guijarro et al.
Objective: To estimate the clinical and economic benefits derived from increasing the use of fixed-dose combinations of high-intensity statins and ezetimibe in patients at high/very high cardiovascular risk, from the pers...
How to achieve LDL cholesterol goals with the funding criteria for new lipid-lowering drugs? [0.03%]
新的血脂调节药物资助标准下的胆固醇治疗目标达成问题
Antón González-Guerrero,Elisenda Climent,David Benaiges et al.
Antón González-Guerrero et al.
Given the apparent inconsistency of having potent lipid-lowering drugs and the unacceptable rate of achievement of therapeutic goals in LDL cholesterol, it is imperative to define new strategies. In this regard, it is appropriate to detail ...
The impact of metabolic syndrome on coronary artery severity in patients with acute myocardial infarction: A perspective from a developing country [0.03%]
代谢综合征对发展中国家急性心肌梗死患者冠状动脉病变严重程度的影响：一项来自发展中国家的回顾性研究
Hai Phuong Nguyen Tran,Tai Nhat Nguyen,Kha Minh Nguyen et al.
Hai Phuong Nguyen Tran et al.
Introduction: Metabolic syndrome (MetS) has been frequently observed in patients with acute myocardial infarction (AMI). However, there is limited research assessing the impact of metabolic syndrome on coronary artery sev...
María José Ariza Corbo,Ovidio Muñiz-Grijalvo,Agustín Blanco Echevarría et al.
María José Ariza Corbo et al.
The development of massive sequencing techniques and guidelines for assessing the pathogenicity of variants are allowing us the identification of new cases of familial chylomicronemia syndrome (FCS) mostly in the LPL gene, less frequently i...
Agustín Blanco Echevarría,María José Ariza Corbo,Ovidio Muñiz-Grijalvo et al.
Agustín Blanco Echevarría et al.
Familial chylomicronemia syndrome (FCS) is a very rare, underdiagnosed disorder that can cause abdominal pain and recurrent pancreatitis from childhood -potentially life-threatening- and chronic complications such as diabetes mellitus and e...
Ovidio Muñiz-Grijalvo,Agustín Blanco Echevarría,María José Ariza Corbo et al.
Ovidio Muñiz-Grijalvo et al.
Multifactorial chylomicronemia associated with multiple comorbidities, drugs and habits is much more common than familial chylomicronemia, an autosomal recessive disease that can be considered as "rare disease". Like the rest of hypertrigly...
Polygenic risk and subclinical atherosclerosis in asymptomatic middle-aged individuals. The ILERVAS study [0.03%]
多基因风险与无症状中年人的亚临床动脉粥样硬化。ILERVAS研究
Emilio Ortega,Amanda Jiménez,Sheila López-Ruiz et al.
Emilio Ortega et al.
Introduction and objectives: More than 50% of first cardiovascular events (CVE) occur in populations identified as at low or intermediate risk by the risk equations, so the inclusion of additional variables, such as polyg...
Strict control of atherogenic cholesterol and cardiovascular disease prevention [0.03%]
严格控制致动脉粥样硬化胆固醇以预防心血管疾病
Carlos Guijarro
Carlos Guijarro
The role of cholesterol associated to low density lipoproteins (LDL) as a causal agent of arteriosclerosis is scientifically consolidated. A number of seminal clinical trials of the highest scientific quality (randomized, controlled, double...
José López-Miranda
José López-Miranda
Hypercholesterolemia is a causal factor of atherosclerotic cardiovascular disease (ASCVD), which is one of the main causes of morbidity and mortality in Spain. The reduction of LDL cholesterol (LDL-C) decreases the risk of ASCVD and adverse...